Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Chankyu | - |
dc.contributor.author | Choi, Seuk Keun | - |
dc.contributor.author | Kim, Rock Ki | - |
dc.contributor.author | Kim, Heeyoun | - |
dc.contributor.author | Whang, Yoon Hee | - |
dc.contributor.author | Pharm, Huyen | - |
dc.contributor.author | Cheon, Hyunwoo | - |
dc.contributor.author | Yoon, Do-Young | - |
dc.contributor.author | Kim, Chan Wha | - |
dc.contributor.author | Baik, Yeong Ok | - |
dc.contributor.author | Park, Sung Soo | - |
dc.contributor.author | Lee, Inhwan | - |
dc.date.accessioned | 2021-09-01T07:48:00Z | - |
dc.date.available | 2021-09-01T07:48:00Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-09 | - |
dc.identifier.issn | 1045-1056 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/63078 | - |
dc.description.abstract | A new 15-valent pneumococcal conjugate vaccine (PCV15) against serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 11A, 14, 18C, 19A, 19F, 22F, and 23F has been developed using aluminum phosphate as an adjuvant. Using the rabbit model, immunogenicity of each serotype was evaluated by measuring antigen specific antibodies and functional antibody titers and comparing them to a control vaccine, Prevnar13 (R). Among the shared serotypes in both PCV15 and Prevnar13 (R), Type 3 and 23F in PCV15 exhibited a lower opsonic index than Prevnar13 (R). Conversely, the other types showed greater or nearly the same immunogenic effects. Type 11A and 22F are two additional serotypes included in PCV15, and only 22F showed a reasonable opsonic index compared with other types. Type 11A exhibited a basal level fold-increase in OPA; thus, we further optimized 11A as well as 3 and 23F by controlling the polysaccharide-to-protein conjugation ratio as a variable. Antibody levels and functional antibody activities were evaluated by ELISA and OPA, and improved levels of immunogenic activities were observed for all three serotypes. In this study, we propose a new PCV15 candidate, in which the common 13 serotypes and a licensed control vaccine have equivalent efficacy while two additional serotypes showed adequate immunogenicity in the rabbit model. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD | - |
dc.subject | PNEUMONIAE VIRULENCE FACTORS | - |
dc.subject | POLYSACCHARIDES | - |
dc.subject | COLONIZATION | - |
dc.subject | PATHOGENS | - |
dc.title | Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chan Wha | - |
dc.identifier.doi | 10.1016/j.biologicals.2019.07.005 | - |
dc.identifier.scopusid | 2-s2.0-85070502469 | - |
dc.identifier.wosid | 000488138100005 | - |
dc.identifier.bibliographicCitation | BIOLOGICALS, v.61, pp.32 - 37 | - |
dc.relation.isPartOf | BIOLOGICALS | - |
dc.citation.title | BIOLOGICALS | - |
dc.citation.volume | 61 | - |
dc.citation.startPage | 32 | - |
dc.citation.endPage | 37 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | PNEUMONIAE VIRULENCE FACTORS | - |
dc.subject.keywordPlus | POLYSACCHARIDES | - |
dc.subject.keywordPlus | COLONIZATION | - |
dc.subject.keywordPlus | PATHOGENS | - |
dc.subject.keywordAuthor | Polyvalent pneumococcal conjugate vaccine | - |
dc.subject.keywordAuthor | Immunogenicity | - |
dc.subject.keywordAuthor | Enzyme-linked immunosorbent assay | - |
dc.subject.keywordAuthor | Opsonophagocytic activity | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.